Showing Results for
- Academic Journals (15)
Search Results
- 15
Academic Journals
- 15
-
From:Future Oncology (Vol. 11, Issue 19) Peer-ReviewedAuthor(s): Nicholas J Ward [*] aff1 , Gemma Westcott aff1 KEYWORDS biomarkers; diagnostics; genomic medicine; oncology; treatment In the 10 years since our launch, the diverse field of oncology has changed...
-
From:Future Oncology (Vol. 11, Issue 19) Peer-ReviewedAuthor(s): Kurt W Fisher aff1 , Antonio Lopez-Beltran aff2 aff3 , Rodolfo Montironi aff4 , Liang Cheng [*] aff1 KEYWORDS BRAF ; colorectal cancer; KRAS ; microsatellite instability; molecular diagnostics; NRAS ;...
-
From:Future Oncology (Vol. 11, Issue 19) Peer-ReviewedAuthor(s): Charlotte Sonigo aff1 aff2 aff3 , Nathalie Sermondade aff4 , Julie Benard aff1 aff2 , Alexandra Benoit aff1 , Joanna Shore aff5 , Christophe Sifer aff4 , Michael Grynberg [*] aff1 aff2 aff6 KEYWORDS...
-
From:Future Oncology (Vol. 11, Issue 19) Peer-ReviewedAuthor(s): Giuseppe Di Lorenzo [*] aff1 , Guru Sonpavde aff2 KEYWORDS castration-resistant stage; chemotherapy; hormone-sensitive stage; hormonal therapy; prostate cancer The past The mainstay of treatment...
-
From:Future Oncology (Vol. 11, Issue 19) Peer-ReviewedAuthor(s): Daniel M Trifiletti aff1 , Timothy N Showalter [*] aff1 KEYWORDS brachytherapy; cervix; CT; MRI; workflow Background Brachytherapy is an established and critical component of the treatment of...
-
From:Future Oncology (Vol. 11, Issue 19) Peer-ReviewedAuthor(s): Enrico Franceschi aff1 , Marco Bartolotti aff1 , Alba A Brandes [*] aff1 KEYWORDS anti-angiogenic; bevacizumab; glioblastoma; recurrent Recurrent glioblastoma (GBM) is characterized by a dismal...
-
From:Future Oncology (Vol. 11, Issue 19) Peer-ReviewedAuthor(s): Simon S Lo [*] aff1 , Ben J Slotman aff2 , Michael Lock aff3 , Yasushi Nagata aff4 , Matthias Guckenberger aff5 , Shankar Siva aff6 , Matthew Foote aff7 , Daniel Tan aff8 , Bin S Teh aff9 , Nina A Mayr aff10...
-
From:Future Oncology (Vol. 11, Issue 19) Peer-ReviewedAuthor(s): Clelia Madeddu aff1 , Giovanni Mantovani [*] aff1 , Giulia Gramignano aff2 , Giorgio Astara aff1 , Antonio Macciò aff3 KEYWORDS advanced cancer; cachexia; IL-6; inflammation; mTOR; muscle wasting;...
-
From:Future Oncology (Vol. 11, Issue 19) Peer-ReviewedAuthor(s): Giuseppe Aprile [*] aff1 , Nicola Silvestris aff2 , Lorenzo Antonuzzo aff3 , Mario Scartozzi aff4 KEYWORDS angiogenesis; gastric cancer; pembrolizumab; ramucirumab; target therapy; translational...
-
From:Future Oncology (Vol. 11, Issue 19) Peer-ReviewedAuthor(s): Johan Vansteenkiste [*] aff1 , Julie Craps aff1 , Nele De Brucker aff1 , Isabelle Wauters aff1 KEYWORDS cancer vaccination; checkpoint inhibitors; immunotherapy; non-small-cell lung cancer; receptors,...
-
From:Future Oncology (Vol. 11, Issue 19) Peer-ReviewedAuthor(s): Ismail Jatoi [*] aff1 KEYWORDS mammography; mortality; overdiagnosis; screening; therapy Ironically, improvements in breast cancer therapy and screening technology are very likely diminishing the...
-
From:Future Oncology (Vol. 11, Issue 19) Peer-ReviewedAuthor(s): Giuseppe Aprile [*] aff1 , Karim Rihawi aff1 , Mario Scartozzi aff2 , Roberto Bordonaro aff3 KEYWORDS antiangiogenics; clinical research; colorectal cancer; EGFR inhibitors; translational research...
-
From:Future Oncology (Vol. 11, Issue 19) Peer-ReviewedAuthor(s): Lev M Berstein [*] aff1 KEYWORDS cancer; endocrinology; hormone; present and future of oncology The past 10 years have been rich in new developments, potentially leading to important breakthroughs in...
-
From:Future Oncology (Vol. 11, Issue 19) Peer-ReviewedAuthor(s): Mandeep S Sagoo aff1 aff2 aff3 , Aleksandra Filipovic aff4 , Lamis Al Harby aff1 aff2 , Justin Stebbing [*] aff4 KEYWORDS rare tumors; retinoblastoma; uveal melanoma Cancers of the eye are rare, but...
-
From:Future Oncology (Vol. 11, Issue 19) Peer-ReviewedAuthor(s): Cédric Rébé [*] aff1 aff2 , François Ghiringhelli aff1 aff2 aff3 KEYWORDS cancer; chemotherapy; immune cells Chemotherapy was first studied for the efficacy of its principal intention, that is, to...